{"id":"W2898644963","doi":"10.1182/blood-2018-99-114960","title":"Atezolizumab in Combination with Daratumumab with or without Lenalidomide or Pomalidomide: A Phase Ib Study in Patients with Multiple Myeloma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Pomalidomide; Lenalidomide; Atezolizumab; Daratumumab; Medicine; Internal medicine; Oncology; Multiple myeloma; Cohort; Tolerability; Cancer; Adverse effect; Immunotherapy; Nivolumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001530027,0.001740131,0.003153988,0.0004592194,0.0005844566,0.001440164,0.0009900465,0.001295734,0.00296324],"category_scores_gemma":[0.0007711768,0.0007893885,0.002387447,0.0006234887,0.0009782359,0.0009317816,0.0005305707,0.003867373,0.0008634626],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001164251,"about_ca_system_score_gemma":0.001943003,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001321636,"about_ca_topic_score_gemma":0.002851851,"domain_scores_codex":[0.999519,0.0001638946,0.00003797282,0.0001112243,0.00006328184,0.0001045848],"domain_scores_gemma":[0.9993636,0.00007599073,0.0001031029,0.00004832523,0.0000378234,0.0003713082],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6947423,0.127235,0.01281799,0.001264711,0.003546857,0.0004642166,0.0003535688,0.001815002,0.0429475,0.0001832611,0.003170737,0.1114588],"study_design_scores_gemma":[0.5183057,0.4546776,0.01943891,0.00004953807,0.001127832,0.0003774609,0.00006192525,0.0007721881,0.00232292,0.0001110643,0.002719645,0.00003517126],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905418,0.004322894,0.0003899634,0.0005192168,0.0001499641,0.001666457,0.0008898744,0.0000715557,0.001448305],"genre_scores_gemma":[0.9887275,0.003400448,0.001199532,0.001085019,0.0002574942,0.00178514,0.001753545,0.00002081811,0.001770507],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003153988,"threshold_uncertainty_score":0.009913027,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02632864527307843,"score_gpt":0.3215447505745981,"score_spread":0.2952161053015196,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}